Cardiovascular risk assessment in the treatment of nonalcoholic steatohepatitis: a secondary analysis of the MOZART trial
Background: Nonalcoholic steatohepatitis (NASH) is associated with increased cardiovascular risk and mortality. No US Food and Drug Administration (FDA) approved therapies for NASH are available; clinical trials to date have not yet systematically assessed for changes in cardiovascular risk. This st...
Những tác giả chính: | Steven C. Lin, Brandon Ang, Carolyn Hernandez, Ricki Bettencourt, Rashmi Jain, Joanie Salotti, Lisa Richards, Yuko Kono, Archana Bhatt, Hamed Aryafar, Grace Y. Lin, Mark A. Valasek, Claude B. Sirlin, Sharon Brouha, Rohit Loomba |
---|---|
Định dạng: | Bài viết |
Ngôn ngữ: | English |
Được phát hành: |
SAGE Publishing
2016-03-01
|
Loạt: | Therapeutic Advances in Gastroenterology |
Truy cập trực tuyến: | https://doi.org/10.1177/1756283X15621232 |
Những quyển sách tương tự
-
Association of noninvasive quantitative decline in liver fat content on MRI with histologic response in nonalcoholic steatohepatitis
Bằng: Janki Patel, et al.
Được phát hành: (2016-09-01) -
Insulin Resistance Increases MRI-Estimated Pancreatic Fat in Nonalcoholic Fatty Liver Disease and Normal Controls
Bằng: Niraj S. Patel, et al.
Được phát hành: (2013-01-01) -
Diagnostic accuracy of two-dimensional shear wave elastography and transient elastography in nonalcoholic fatty liver disease
Bằng: Suzanne R. Sharpton, et al.
Được phát hành: (2021-10-01) -
Changes in the gut microbiome associated with liver stiffness improvement in nonalcoholic steatohepatitis
Bằng: Suzanne R. Sharpton, et al.
Được phát hành: (2022-05-01) -
Polyunsaturated fatty acid metabolites as novel lipidomic biomarkers for noninvasive diagnosis of nonalcoholic steatohepatitis1
Bằng: Rohit Loomba, et al.
Được phát hành: (2015-01-01)